-
Product Insights
NewLikelihood of Approval Analysis for Interstitial Lung Fibrosis
Overview How likely is it that the drugs in Interstitial Lung Fibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Interstitial Lung Fibrosis Overview Interstitial Lung Fibrosis or interstitial lung disease...
-
Product Insights
NewNet Present Value Model: Inhibrx Inc’s INBRX-101
Empower your strategies with our Net Present Value Model: Inhibrx Inc's INBRX-101 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed based...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CUSP-06 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CUSP-06 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CUSP-06 in Ovarian Cancer Drug Details: CUSP-06 (AMT-707) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CUSP-06 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CUSP-06 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CUSP-06 in Solid Tumor Drug Details: CUSP-06 (AMT-707) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-211 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-211 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-211 in Ovarian Cancer Drug Details: BNT-211 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-211 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-211 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-211 in Gastric Cancer Drug Details: BNT-211 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-211 in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-211 in Sarcomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-211 in Sarcomas Drug Details: BNT-211 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-211 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-211 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-211 in Endometrial Cancer Drug Details: BNT-211 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-211 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-211 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-211 in Non-Small Cell Lung Cancer Drug Details: BNT-211...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-211 in Uterine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-211 in Uterine Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-211 in Uterine Cancer Drug Details: BNT-211 is under development for...